Hugh Auchincloss | |
---|---|
Director of the National Institute of Allergy and Infectious Diseases | |
Acting 1 January 2023 –24 September 2023 | |
Preceded by | Anthony Fauci |
Succeeded by | Jeanne Marrazzo |
Personal details | |
Born | Hugh Auchincloss Jr. [1] March 15,1949 New York City,U.S. |
Spouse | |
Children | 3, including Jake |
Education | Yale University (BA, MA) Harvard University (MD) |
Hugh Auchincloss, Jr. (pronounced: aa-kuhn-klaas; born March 15, 1949) is an American immunologist and physician who served as the acting director of the National Institute of Allergy and Infectious Diseases from January to August 2023. Previously, he was the principal deputy director of the NIAID, from 2006 to 2022. Prior to government service, Auchincloss was a transplant surgeon and full professor of surgery at Harvard Medical School, and researched at Massachusetts General Hospital for 17 years.
Hugh Auchincloss, Jr., was born in New York City on March 15, 1949 [1] to Hugh Auchincloss, Sr. (1915−1998), and Katharine Lawrence Bundy. His mother was the daughter of lawyer Harvey Hollister Bundy, and the granddaughter of banker William Lowell Putnam. Auchincloss Sr., was a surgeon at Columbia University and The Valley Hospital. [2] His father is the first cousin once-removed of stockbroker Hugh D. Auchincloss. [3]
Auchincloss graduated from Groton School. [4] At Yale University, he completed an A.B. magna cum laude in political science and economics in 1972, and a master's degree in economics. [4] [5] Auchincloss graduated with Phi Beta Kappa honors. He completed his M.D. from Harvard Medical School in 1976. [5]
Auchincloss was a transplant surgeon and professor of surgery at Harvard Medical School. For more than 17 years he operated a laboratory in transplantation immunology at Massachusetts General Hospital. His initial area of interest was in xenotransplantation. [5] In 1998, he founded the Juvenile Diabetes Research Foundation Center for Islet Transplantation and served as its director until 2003. He subsequently served as chief operating officer of the NIAID Immune Tolerance Network. [6]
In 2006, he joined the National Institute of Allergy and Infectious Diseases (NIAID) as the principal deputy director. [6] He led the development of the Institute's strategic plan and chaired the NIAID Research Initiative Committee, an internal governance group that designed and implemented a more efficient approach to planning, developing, and approving NIAID initiatives. Auchincloss is part of an NIAID senior leadership group responsible for reviewing all aspects of HIV/AIDS research policy, including the evaluation of “test and treat” strategies, analysis of results of pre-exposure prophylaxis (PrEP) clinical trials (including microbicide trials), and coordination of future HIV/AIDS vaccine clinical trials. [5]
Auchincloss has served as the NIH point of contact for the Emergency Use Authorization program since 2006. [5]
In January 2023, Auchincloss succeeded Anthony Fauci as the acting NIAID director. [7] He served in the position until the seventh NIAID director, Jeanne Marrazzo, was appointed in August 2023. [8]
Emails between Dr. Anthony Fauci and Auchincloss regarding NIAID involvement in gain-of-function research and the COVID-19 pandemic were featured during a hearing of the Republican House Energy and Commerce Committee on 2 June 2021. [9]
Auchincloss was elected president of the American Society of Transplantation in 2005. He has authored scientific articles and texts and serves on the editorial boards of scientific publications. [6] Auchincloss is on federal and NIH-wide committees, including the Trans-Federal Task Force on Optimizing Biocontainment Oversight, the National Security Strategy/Office of Science and Technology Policy on Optimizing Biological Select Agents and Toxins Working Group, and the National Biodefense Science Board. He was appointed as co-chair of the International Clinical Research Subcommittee of the NIH Global Health Research Working Group and as a member of the NIH and Translational Science Awards Advisory Board. [5]
On August 26, 1973, Auchincloss married Laurie Glimcher at the Memorial Church of Harvard University; they were both first-year Harvard Medical School students. [4] They had 3 children including politician Jake Auchincloss. [10] [11] In 2010, he married Mary L. McCain Ph.D.
The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
Anthony Stephen Fauci is an American physician-scientist and immunologist who served as the director of the National Institute of Allergy and Infectious Diseases (NIAID) from 1984 to 2022, and the chief medical advisor to the president from 2021 to 2022. Fauci was one of the world's most frequently cited scientists across all scientific journals from 1983 to 2002. In 2008, President George W. Bush awarded him the Presidential Medal of Freedom, the highest civilian award in the United States, for his work on the AIDS relief program PEPFAR.
VaxGen was a biopharmaceutical company based in the San Francisco Bay Area.
The National Emerging Infectious Diseases Laboratories (NEIDL), is a biosciences facility of Boston University located on Albany street, within the clinical and biopharma hub of the South End neighborhood of Boston, Massachusetts.
Albert Zaven Kapikian (1930–2014) was an Armenian-American virologist who developed the first licensed vaccine against rotavirus, the most common cause of severe diarrhea in infants. He was awarded the Sabin Gold Medal for his pioneering work on the vaccine. He is the 13th recipient of this recognition, awarded annually by the Sabin Vaccine Institute. Called the father of human gastroenteritis virus research, Kapikian identified the first norovirus, initially called Norwalk virus, in 1972; and he and his colleagues at the National Institutes of Health identified the hepatitis A virus in 1973.
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.
Robert Merritt Chanock was an American pediatrician and virologist who made major contributions to the prevention and treatment of childhood respiratory infections in more than 50 years spent at the National Institute of Allergy and Infectious Diseases.
Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019. Glimcher has been at the center of controversies related to animal rights activists, excessive corporate payments, and research misconduct.
The Foundation for the National Institutes of Health (FNIH) is a not-for-profit, 501(c)(3) charitable organization established by the US Congress in 1990. Located in North Bethesda, MD, the FNIH raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).
Peter B. Jahrling is chief of the Emerging Viral Pathogens Section of the National Institute of Allergy and Infectious Diseases.
John I. Gallin is an American medical researcher who has contributed to the understanding of innate immunity but especially chronic granulomatous disease, a phagocyte disorder. Gallin was appointed director of the NIH Clinical Center on May 1, 1994, and served until January 8, 2017. He serves as the chief scientific officer for the Clinical Center and associate director for clinical research at the National Institutes of Health.
Emily J. Erbelding is an American physician-scientist. She is the director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Erbelding was previously deputy director of the Division of AIDS at NIAID. She was a faculty member at Johns Hopkins School of Medicine and served as director of clinical services for the Baltimore City Health Department STD/HIV program.
Jacob Daniel Auchincloss is an American politician and businessman serving as the U.S. representative for Massachusetts's 4th congressional district since 2021. He is a member of the Democratic Party.
Lori Elizabeth Dodd is an American mathematical statistician specializing in clinical trials methodology, statistical analysis of genomic data, design of clinical trials using biomarkers and imaging modalities, and statistical methods for analyzing biomarkers. She is a statistician in the biostatistics research branch at the National Institute of Allergy and Infectious Diseases.
Jeanne Marisa Marrazzo is an American physician-scientist and infectious diseases specialist. She was the director of the University of Alabama School of Medicine Division of Infectious Diseases and focused on prevention of HIV infection using biomedical interventions. Marrazzo is a fellow of the American College of Physicians and Infectious Disease Society of America. On August 2, 2023 Lawrence A. Tabak, acting director for the National Institutes of Health (NIH), named Jeanne M. Marrazzo as director of NIH’s National Institute of Allergy and Infectious Diseases.
Dr. Michael J. Lenardo, is the chief of the Molecular Development and Immune System Section and the founder and co-Director of the Clinical Genomics Program at the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH). Trained as a geneticist, molecular biologist, and immunologist, his research examines how cells of the immune system defend themselves against various pathogens, including viruses and bacteria. His research has investigated genetic abnormalities in the immune system, mechanisms of cell death, genetic diseases of immune homeostasis and autoimmunity, and development of novel diagnostics and therapeutics for diseases of the immune system. Lenardo's contributions to science and medicine have shown the possibilities of genomic research in developing precision medicine diagnoses and treatments for disease in humans. In 2006 he was appointed Officer of the Most Excellent Order of the British Empire (O.B.E.) by Queen Elizabeth II. In 2019 he was inducted into the National Academies of Sciences and the National Academy of Medicine, considered among the highest honors awarded to a U.S scientist and medical researcher respectively.
Hilary D. Marston is an American physician-scientist and global health policy advisor specializing in pandemic preparedness. She is the Chief Medical Officer of the Food and Drug Administration.
Tara N. Palmore is an American physician-scientist and epidemiologist specializing in patient safety through prevention of hospital-acquired infections. As of 2021 she was the hospital epidemiologist at George Washington University School of Medicine and Health Sciences.
John R. Mascola is an American physician-scientist, immunologist and infectious disease specialist. He was the director of the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ModeX Therapeutics.
Dorland Jones Davis was an American physician, commissioned officer in the U.S. Public Health Service (PHS). He was the director of the National Institute of Allergy and Infectious Diseases from 1964 to 1975. Davis was born in Chicago, Illinois, on July 2, 1911. He received a B.S. degree from the University of Illinois in 1933, an M.D. degree from Johns Hopkins University in 1937, and a DrPH degree from Johns Hopkins in 1940.
Marrazzo is expected to begin her role in the fall, the NIH said. She will take over from Dr. Hugh Auchincloss Jr., who has served as acting director since Dr. Anthony Fauci stepped down from the post in December.
on February 1, 2020, Dr. Fauci exchanged emails with Dr. Auchincloss about timing of gain of function research and grant funding at the NIH.